These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16320453)

  • 21. Drug-eluting stents in primary PCI.
    Jneid H; Maree AO; Palacios IF
    N Engl J Med; 2006 Dec; 355(23):2483-4; author reply 2484-6. PubMed ID: 17162758
    [No Abstract]   [Full Text] [Related]  

  • 22. Are drug-eluting stents the preferred treatment for multivessel coronary artery disease?
    Klein LW
    J Am Coll Cardiol; 2006 Jan; 47(1):22-6. PubMed ID: 16386659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Drug-eluting stents: do they keep their promises?].
    Nordmann A
    Praxis (Bern 1994); 2006 Apr; 95(15):581-3. PubMed ID: 16640178
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison between sirolimus- and paclitaxel-eluting stent in T-cell subsets redistribution.
    Sardella G; De Luca L; Di Roma A; De Persio G; Conti G; Paroli M; Fedele F
    Am J Cardiol; 2006 Feb; 97(4):494-8. PubMed ID: 16461044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Healing Achilles--sirolimus versus paclitaxel.
    Moliterno DJ
    N Engl J Med; 2005 Aug; 353(7):724-7. PubMed ID: 16105991
    [No Abstract]   [Full Text] [Related]  

  • 26. Safety of drug-eluting stents in the coronary artery in ST-elevation myocardial infarction at a single high-volume medical center.
    Bose R; Gupta G; Grayburn PA; Laible EA; Kang MJ; Choi JW
    Am J Cardiol; 2007 Sep; 100(6):949-52. PubMed ID: 17826375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive factors of restenosis after coronary implantation of sirolimus- or paclitaxel-eluting stents.
    Kastrati A; Dibra A; Mehilli J; Mayer S; Pinieck S; Pache J; Dirschinger J; Schömig A
    Circulation; 2006 May; 113(19):2293-300. PubMed ID: 16682614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug-eluting stents show delayed healing: paclitaxel more pronounced than sirolimus.
    van Beusekom HM; Saia F; Zindler JD; Lemos PA; Swager-Ten Hoor SL; van Leeuwen MA; de Feijter PJ; Serruys PW; van der Giessen WJ
    Eur Heart J; 2007 Apr; 28(8):974-9. PubMed ID: 17434882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Drug eluting stents--end of restenosis?].
    Groch L
    Vnitr Lek; 2004 Oct; 50 Suppl 1():S59-62. PubMed ID: 15651142
    [No Abstract]   [Full Text] [Related]  

  • 30. Drug-eluting stent for the treatment of small coronary lesion: comparison between sirolimus- and paclitaxel-eluting stent.
    Li JJ; Xu B; Yang YJ; Chen JL; Qiao SB; Ma WH; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL
    Chin Med J (Engl); 2007 Apr; 120(7):569-73. PubMed ID: 17442204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences in restenosis rate with different drug-eluting stents in patients with and without diabetes mellitus: a report from the SCAAR (Swedish Angiography and Angioplasty Registry).
    Fröbert O; Lagerqvist B; Carlsson J; Lindbäck J; Stenestrand U; James SK
    J Am Coll Cardiol; 2009 May; 53(18):1660-7. PubMed ID: 19406341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug eluting stents in 2005.
    Gershlick AH
    Heart; 2005 Jun; 91 Suppl 3(Suppl 3):iii24-31. PubMed ID: 15919649
    [No Abstract]   [Full Text] [Related]  

  • 33. Early outcome of treatment of ostial de novo left anterior descending coronary artery lesions with drug-eluting stents.
    Tsagalou E; Stankovic G; Iakovou I; Melzi G; Cosgrave J; Ge L; Michev I; Chieffo A; Airoldi F; Carlino M; Montorfano M; Colombo A
    Am J Cardiol; 2006 Jan; 97(2):187-91. PubMed ID: 16442360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Efficacy of sirolimus-eluting stents in diabetics with complex coronary lesions].
    Berenguer A; Mainar V; Bordes P; Valencia J; Gómez S
    Rev Esp Cardiol; 2006 Feb; 59(2):117-24. PubMed ID: 16540032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The "0%" restenosis study.
    Colombo A
    Ital Heart J; 2002 Oct; 3(10):559-6. PubMed ID: 12478812
    [No Abstract]   [Full Text] [Related]  

  • 36. How drug-eluting stents keep coronary blood flowing.
    Oliver B; Sharma SK; Ayello EA
    Nursing; 2005 Feb; 35(2):36-41; quiz 41-2. PubMed ID: 15706276
    [No Abstract]   [Full Text] [Related]  

  • 37. Coronary in-stent restenosis in diabetic patients after implantation of sirolimus or paclitaxel drug-eluting coronary stents.
    Kitoga M; Pasquet A; Preumont V; Kefer J; Hermans MP; Vanoverschelde JL; Buysschaert M
    Diabetes Metab; 2008 Feb; 34(1):62-7. PubMed ID: 18069029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative healing response after sirolimus- and paclitaxel-eluting stent implantation in a pig model of restenosis.
    Silva GV; Fernandes MR; Madonna R; Clubb F; Oliveira E; Jimenez-Quevedo P; Branco R; Lopez J; Angeli FS; Sanz-Ruiz R; Vaughn WK; Zheng Y; Baimbridge F; Canales J; Cardoso CO; Assad JA; Falotico R; Perin EC
    Catheter Cardiovasc Interv; 2009 May; 73(6):801-8. PubMed ID: 19309735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative clinical outcomes of paclitaxel- and sirolimus-eluting stents: results from a large prospective multicenter registry--STENT Group.
    Simonton CA; Brodie B; Cheek B; Krainin F; Metzger C; Hermiller J; Juk S; Duffy P; Humphrey A; Nussbaum M; Laurent S;
    J Am Coll Cardiol; 2007 Sep; 50(13):1214-22. PubMed ID: 17888837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. All drug-eluting stents are equal, but some drug-eluting stents are more equal than others.
    Strauss BH
    J Am Coll Cardiol; 2006 Oct; 48(7):1310-1. PubMed ID: 17010787
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.